Trilogy Metals Inc. annual report, FY2018

Trilogy Metals Inc. — FY2018 Form 10-K

Reporting period: Fiscal year ended November 30, 2018; fourth-quarter results are for the three months ended that date. The filing was dated February 8, 2019. Amounts are in U.S. dollars unless stated otherwise.

Business context

Trilogy is an Alaska-focused mineral exploration and development company with no producing mines or mining operating revenue. Its Upper Kobuk Mineral Projects comprise the Arctic polymetallic project and the Bornite copper project in Northwest Alaska. The company’s strategy is to advance Arctic toward feasibility and permitting, continue Bornite exploration, and pursue value-accretive transactions.

Financial performance and position

MetricFY2018FY2017
Revenue from mining operationsNoneNone
Net loss$21.849 million$21.104 million
Loss per share, basic and diluted$0.18$0.20
Operating cash used$22.070 million$15.411 million
Cash and cash equivalents at year-end$22.991 million$5.391 million
Working capital$21.976 million$4.851 million
Total assets$54.659 million$40.279 million
Total liabilities$22.457 million$14.614 million
Shareholders’ equity$32.202 million$25.665 million

FY2018 investing activities provided $12.725 million, including $10.435 million in South32 project funding and $2.297 million from selling the remaining GoldMining Inc. investments. Financing activities provided $26.945 million net, primarily from the April share offering. Cash increased by $17.600 million during the year. The filing reports no material off-balance-sheet arrangements and no conventional borrowings; year-end liabilities included a $20.800 million South32 mineral-properties purchase option liability.

Fourth-quarter net loss was $5.319 million, versus $6.726 million in Q4 2017. Mineral-property expense was $3.833 million, compared with $4.693 million; management attributed the decrease mainly to the 2018 camp closing earlier.

Material changes and project economics

  • Net loss increased from FY2017, principally as mineral-property expenses rose to $16.490 million from $15.100 million amid expanded project programs. Higher salaries and stock-based compensation also contributed. Loss per share declined to $0.18 from $0.20, reflecting a larger weighted-average share count.
  • April 2018’s bought-deal offering issued 24,784,482 shares at $1.16 per share, raising $28.750 million gross and $26.945 million net. Shares outstanding at November 30, 2018 were 131,585,612.
  • The Arctic 2018 pre-feasibility study projected $779.6 million initial capital, a 12-year operating life after three years of construction, and average operating costs of $46.81 per tonne milled. At study assumptions, estimated pre-tax NPV at an 8% discount rate was $1.935 billion with a 38.0% IRR; post-tax NPV was $1.413 billion with a 33.4% IRR. These are project-study estimates, not historical company results, and depend on assumptions and execution.
  • The Arctic study reported 43.038 million tonnes of probable reserves under Canadian reporting standards. The filing separately states Trilogy has no known reserves under SEC Industry Guide 7; investors should not treat Canadian resource or reserve classifications as equivalent to U.S. SEC reserve classifications.
  • Bornite’s June 2018 estimate included 77 million pounds of inferred cobalt resources. Copper resources were unchanged from the prior estimate; the 2017 step-out drilling was too widely spaced to support resource additions.

Outlook, risks and contingencies

  • For FY2019, Trilogy approved an $18.2 million UKMP program: $9.2 million for South32-funded Bornite work, $7.0 million for Arctic feasibility-level engineering and environmental work, and $2.0 million for regional exploration funded equally by Trilogy and South32. Management anticipated completing the Arctic feasibility study in the first half of 2020.
  • South32’s option provides for up to three annual funding tranches; its final $9.2 million FY2019 tranche was expected by February 12, 2019. South32 may elect to form a 50/50 joint venture, contributing a minimum of $150 million subject to agreement terms, and must exercise by January 31, 2020. The option funding is not guaranteed beyond contractual commitments.
  • The Arctic project’s development depends materially on permitting and construction of the proposed Ambler Mining District Industrial Access Project road, as well as substantial infrastructure, financing, further studies, and regulatory approvals. The PFS economics exclude the potential impact of South32’s joint-venture option and NANA’s right to elect a 16%–25% project interest or a 15% net-proceeds royalty.
  • Principal risks include no operating revenue and continuing losses, future financing needs and potential dilution, volatile metal prices, remote Alaska location and seasonal work, permitting and environmental uncertainty, infrastructure and cost overruns, and uncertainty in resource estimates and project economics. Trilogy believed it was a passive foreign investment company for U.S. tax purposes in FY2018, potentially creating adverse U.S. tax consequences for U.S. shareholders.
  • No material current, pending, or threatened litigation was reported. Management and the auditor concluded internal control over financial reporting was effective; the auditor issued an unqualified opinion on the financial statements.

Most important facts for investors to verify

  • Whether the South32 FY2019 funding was received and whether South32 exercises its joint-venture option before the deadline.
  • Whether Arctic feasibility work supports the PFS cost, schedule, metal-price, recovery, and economic assumptions, including the proposed access road and permitting timeline.
  • The distinction between Canadian NI 43-101 reserve/resource disclosures and the company’s statement that it has no reserves recognized under SEC Industry Guide 7.
  • Whether cash and committed funding are sufficient for planned work, corporate costs, and the company’s continuing operating cash outflows.
  • Potential project economics and ownership effects of NANA’s back-in or royalty rights, and the dilution impact of outstanding options, warrants, and future equity financing.